We can't find the internet
Attempting to reconnect
16447.2 PFLS-LS
16447.2 PFLS-LS
Résumé
Inhibitory therapeutics of Death Receptor 3 (DR3) for treatment of autoimmune disorders
Textes supplémentaires
Abstract
The project is a multi-faceted approach towards identification of a novel treatment of autoimmune disorders such as IBD and RA. AIDD, in collaboration with UNIGE, will identify small molecule inhibitors of Death Receptor 3 (DR3) using an innovative combined biosensor - fragment screening - nanobody screening approach. The output of this project will be a series of first family hit DR3 inhibitors demonstrating promise for further optimization towards drug candidates.
Participants
Jeannine Huck
Wirtschaftspartner
jhuck@jcfiduciaire.ch
AIDD Jeannine Huck Bâtiment C / EPFL Innovation Park 1015 Lausanne VD CH
Leonardo Scapozza
Kontaktperson
leonardo.scapozza@unige.ch
Université de Genève Leonardo Scapozza Quai Ernest-Ansermet 30 1211 Genève GE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2014-08-31
- Date de fin
- 2015-08-31
- Coûts totaux approuvés
- CHF 238063.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%